Enhanced Anti-Adhesive Barrier Membrane for Biomedical Applications

An improved anti-adhesive barrier membrane utilizing a unique interpenetrating, crosslinked network with enhanced porosity, biocompatibility, and non-toxicity, selectively inhibiting fibroblast infiltration into surgical microenvironments.

The original patent's anti-adhesive barrier membrane, comprising alginate and hyaluronic acid, demonstrated limitations in terms of physical strength, in vivo reposition flexibility, and handling. The new inventive concept addresses these limitations by introducing a unique interpenetrating, crosslinked network with improved porosity, enhancing the membrane's overall performance and usability.

The enhanced anti-adhesive barrier membrane consists of a unique interpenetrating, crosslinked network of hyaluronic acid and alginate, exhibiting improved physical strength, flexibility, and handling. This novel structure enables the membrane to selectively inhibit fibroblast infiltration into surgical microenvironments, reducing the risk of adhesions and promoting improved healing outcomes. The membrane's non-toxic, biodegradable, and biocompatible nature ensures its safety and efficacy in various biomedical applications.

The new inventive concept's unique interpenetrating, crosslinked network with enhanced porosity and selective fibroblast inhibition represents a significant improvement over the original patent's design, providing a non-obvious solution to the limitations of the prior art.

Alternative embodiments of the inventive concept may include varying the ratio of hyaluronic acid to alginate, incorporating additional biocompatible polymers, or modifying the crosslinking process to further enhance the membrane's properties. These variations could enable the development of customized membranes tailored to specific biomedical applications.

The enhanced anti-adhesive barrier membrane has significant commercial potential in various biomedical applications, including surgical implants, wound dressings, and tissue engineering. The target market includes medical device manufacturers, pharmaceutical companies, and research institutions focused on developing innovative biomedical solutions.